X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (60) 60
humans (54) 54
clarithromycin (28) 28
female (27) 27
helicobacter pylori (27) 27
pharmacology & pharmacy (27) 27
male (26) 26
short-term (26) 26
helicobacter infections - drug therapy (25) 25
gastroenterology & hepatology (23) 23
adult (21) 21
anti-bacterial agents - therapeutic use (21) 21
middle aged (21) 21
short-term treatment (18) 18
anti-ulcer agents - therapeutic use (15) 15
drug therapy, combination (15) 15
azithromycin (14) 14
efficacy (14) 14
risk factors (14) 14
aged (13) 13
anti-bacterial agents - administration & dosage (13) 13
clarithromycin - therapeutic use (13) 13
anti-bacterial agents - adverse effects (12) 12
antibiotics (12) 12
clarithromycin - administration & dosage (12) 12
eradication (12) 12
infection (12) 12
medicine & public health (12) 12
drug administration schedule (11) 11
omeprazole (11) 11
omeprazole - therapeutic use (11) 11
treatment outcome (11) 11
double-blind (10) 10
clarithromycin - adverse effects (9) 9
duodenal-ulcer (9) 9
mortality (9) 9
short-term clarithromycin (9) 9
abridged index medicus (8) 8
anti-ulcer agents - administration & dosage (8) 8
dose triple therapy (8) 8
drug therapy (8) 8
prospective studies (8) 8
short term (8) 8
adolescent (7) 7
bordetella-pertussis (7) 7
lansoprazole (7) 7
metronidazole (7) 7
peptic-ulcer (7) 7
triple therapy (7) 7
amoxicillin (6) 6
bismuth - therapeutic use (6) 6
cardiac & cardiovascular systems (6) 6
care and treatment (6) 6
erythromycin (6) 6
follow-up studies (6) 6
helicobacter pylori - drug effects (6) 6
infectious diseases (6) 6
medicine, general & internal (6) 6
metronidazole - therapeutic use (6) 6
omeprazole - administration & dosage (6) 6
ranitidine bismuth citrate (6) 6
research (6) 6
time factors (6) 6
toxicology (6) 6
2-pyridinylmethylsulfinylbenzimidazoles (5) 5
aged, 80 and over (5) 5
amoxicillin - administration & dosage (5) 5
animals (5) 5
anti-ulcer agents - adverse effects (5) 5
clinical neurology (5) 5
dosage and administration (5) 5
infant (5) 5
internal medicine (5) 5
macrolides (5) 5
management (5) 5
omeprazole - analogs & derivatives (5) 5
pharmacology/toxicology (5) 5
pneumonia (5) 5
proton pump inhibitor (5) 5
randomized controlled-trial (5) 5
short-term triple therapy (5) 5
studies (5) 5
therapy (5) 5
adults (4) 4
adverse events (4) 4
amoxicillin - therapeutic use (4) 4
analysis (4) 4
arrhythmia (4) 4
azithromycin - administration & dosage (4) 4
azithromycin - therapeutic use (4) 4
campylobacter-pylori (4) 4
coronary-heart-disease (4) 4
dose-response relationship, drug (4) 4
duodenal ulcer - drug therapy (4) 4
epidemiology (4) 4
eradication therapy (4) 4
helicobacter infections - diagnosis (4) 4
helicobacter infections - microbiology (4) 4
helicobacter-pylori infection (4) 4
medicine (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMJ : British Medical Journal, ISSN 0959-8138, 3/2013, Volume 346, Issue 7902, pp. 12 - 12
Journal Article
Journal of Psychopharmacology, ISSN 0269-8811, 7/2014, Volume 28, Issue 7, pp. 697 - 702
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 3, pp. e9836 - e9836
Antibiotic administration is the standard treatment for the bacterium Helicobacter pylori, the main causative agent of peptic ulcer disease and gastric cancer.... 
CLARITHROMYCIN | RESISTANCE GENES | INTESTINAL MICROFLORA | HELICOBACTER-PYLORI INFECTION | FLORA | PERSISTENCE | BIOLOGY | POPULATIONS | MACROLIDE RESISTANCE | GRADIENT GEL-ELECTROPHORESIS | 16S RIBOSOMAL-RNA | Oligonucleotides - genetics | Dyspepsia - drug therapy | Humans | Metronidazole - administration & dosage | Omeprazole - administration & dosage | Gastrointestinal Tract - microbiology | Gastrointestinal Tract - drug effects | Drug Resistance, Microbial - genetics | Phylogeny | Case-Control Studies | Anti-Bacterial Agents - therapeutic use | Polymorphism, Restriction Fragment Length | Time Factors | Clarithromycin - administration & dosage | RNA, Ribosomal, 16S - genetics | Feces | Pharynx - drug effects | Pharynx - microbiology | Drug resistance in microorganisms | Care and treatment | Antibiotics | Microbiota (Symbiotic organisms) | RNA | Analysis | Peptic ulcer | Stomach cancer | Antiulcer drugs | Short term | Microbial activity | Clarithromycin | rRNA 16S | Microbiology | Genes | Colorectal cancer | Biology | Drug resistance | Gene polymorphism | Data bases | Microorganisms | Helicobacter pylori | Intestine | Antibiotic resistance | Phylogenetics | Bacteria | Gastric cancer | Deoxyribonucleic acid--DNA | Pharynx | Disease control | Bacteriology | Polymerase chain reaction | Infectious diseases | Restriction fragment length polymorphism | Metronidazole | Cancer | Long-term effects | Polymorphism | Index Medicus | ULCERS | ANTIBIOTICS | DISEASES | THERAPY | NEOPLASMS | GENES | FECES | COMMUNITIES | METRONIDAZOLE | Microbial/genetics | Ribosomal | Pharynx/drug effects/microbiology | Restriction Fragment Length | Gastrointestinal Tract/drug effects/microbiology | Clarithromycin/administration & dosage | Omeprazole/administration & dosage | Metronidazole/administration & dosage | Oligonucleotides/genetics | Naturvetenskap | Natural Sciences | Dyspepsia/drug therapy | 16S/genetics | Anti-Bacterial Agents/therapeutic use | Drug Resistance | Deoxyribonucleic acid | DNA
Journal Article
Journal Article
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 01/2019, Volume 2019, Issue 1, pp. CD011825 - CD011825
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 09/2018, Volume 62, Issue 9
The duration of therapy for community-acquired pneumonia (CAP) remains undefined. We sought to investigate whether short-course antibiotic treatment for CAP is... 
Short term | Chlamydia pneumoniae | Pneumonia | Influenza | Mortality | Extended | Mycoplasma pneumoniae | Haemophilus influenzae | Prolonged | Streptococcus pneumoniae | influenza | CLARITHROMYCIN | MULTICENTER | SAFETY | TOLERANCE | MICROBIOLOGY | prolonged | extended | short term | MILD | 10-DAY COURSE | THERAPY | pneumonia | 3-DAY AZITHROMYCIN | LEVOFLOXACIN | ERYTHROMYCIN | mortality | PHARMACOLOGY & PHARMACY
Journal Article